| Quarter | Score |
|---|---|
| 2013-Q2 | 49.8 |
| 2013-Q3 | 49.5 |
| 2013-Q4 | 49.7 |
| 2014-Q1 | 49.5 |
| 2014-Q2 | 49.6 |
| 2014-Q3 | 50.0 |
| 2018-Q1 | 49.2 |
| 2018-Q2 | 50.7 |
| 2018-Q3 | 50.3 |
| 2019-Q2 | 52.7 |
| 2022-Q1 | 49.8 |
| 2022-Q3 | 67.8 |
| 2022-Q4 | 51.0 |
| 2023-Q1 | 49.0 |
| 2023-Q2 | 73.0 |
| 2023-Q3 | 48.4 |
| 2023-Q4 | 66.3 |
| 2024-Q1 | 74.8 |
| 2024-Q2 | 61.7 |
| 2024-Q3 | 58.4 |
| 2024-Q4 | 57.6 |
| 2025-Q1 | 55.5 |
| 2025-Q2 | 56.1 |
| 2025-Q3 | 52.6 |
| 2025-Q4 | 48.1 |
Funds reducing exposure or consensus momentum fading
Trading 11.0% below funds' estimated purchase price
1 of 16 tracked funds hold CMG. Avg conviction: 2.4%. Net holding. First tracked at $37.00 (current -11.0% vs tracked).
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 16 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Third Point | 2.4% | New Buy |